NDRA: ENDRA Price to Sales

Corporate company logo of ENDRA Life Sciences Inc (NDRA)

Competition with traditional ultrasound manufacturers impacts credit risks, yet the price-to-sales dynamics of ENDRA Life Sciences (NDRA) demonstrate price stability. The value of describes the current multiplier level. Financial potential is based on the implementation of TAEUS systems in clinics, while stability is supported by efficient production and a scalable cloud IT sector, which minimizes the depreciation of fixed assets.

NDRA (ENDRA Life Sciences Inc) P/S Multiple history from 07/04/2022 to 11/13/2026

Analytical breakdowns for ENDRA (NDRA)

- share price and consensus valuation forecast:
Price Performance Chart endrainc.com|NDRA - Analyst Consensus Forecast
- market capitalization information:
Market Value ENDRA|NDRA - Total Company Value
- shareholders' equity book value data:
Equity per Share ENDRA Life Sciences|NDRA - Book Capitalization|Capitalization to Book Value Ratio endrainc.com|NDRA - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio ENDRA Life Sciences|NDRA - Long-Term Debt to Capital|Short-Term Debt to Capital ENDRA Corp|NDRA - Company Total Debt|Debt to Net Assets Ratio ENDRA|NDRA - Company Long-Term Debt|Company Short-Term Debt ENDRA Life Sciences|Interim Coverage Ratio endrainc.com
- net income and valuation multiples indicators:
NDRA - Net Profit|Forward Earnings ENDRA Life Sciences|NDRA - P/E Multiple|Projected Price to Earnings Ratio ENDRA Life Sciences Inc|NDRA - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation ENDRA|NDRA - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters ENDRA Life Sciences|NDRA - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months endrainc.com|NDRA - Earnings growth in current year|Consensus forecast of earnings per share growth for next year ENDRA Life Sciences
- issuer revenue and sales details:
NDRA - Revenue and Sales Volume|Company Expected Sales Volume endrainc.com|NDRA - Price-to-Revenue Ratio|Market Cap to Projected Revenue ENDRA
Summary company analytics:endrainc.com, NDRA
Finished products of ENDRA

The P/S multiple determines the market value of a business relative to its annual sales volume, allowing for an assessment of asset monetization efficiency regardless of net income. Analysis of the price-to-sales ratio reveals the market's immediate reaction to financial reports, which for ENDRA Life Sciences (NDRA) confirms the capitalization of a stable core team of diagnostic software developers and ultrasound system engineers.

Competitors of ENDRA Life Sciences

ARWR (arrowheadpharma.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple MIRM (Mirum)|Dynavax Corp (DVAX) - Price to Sales|ABUS - Price-to-Revenue Ratio|IVA (Inventiva Corp) - Market Cap to Revenue Ratio|GYRE: P/S Multiple|Market Cap to Revenue Ratio ASMB|Price-to-Revenue Ratio Galectin Therapeutics, Inc.|GNFT: Market Capitalization-to-Revenue Ratio|P/S Multiple DRRX|P/S Multiple aligos.com (ALGS)|BioVie - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio GLMD|HEPA - Price-to-Revenue Ratio